| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 17 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 |
| 2 | TACROLIMUS OINTMENT 0.1% | 17 |
| 3 | PREDNISONE | 15 |
| 4 | MYCOPHENOLATE MOFETIL | 12 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 12 |
| 6 | PREDNISOLONE | 9 |
| 7 | PREDNISOLONE ORAL | 9 |
| 8 | PREDNISOLONE ORAL SOLUTION | 9 |
| 9 | METHYLPREDNISOLONE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUCYTOSINE | 2 | 0.0014 |
| 1 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 3 | 0.0004 |
| 2 | POTASSIUM CITRATE | 2 | 0.0004 |
| 3 | MYCOPHENILIC ACID | 5 | 0.0002 |
| 4 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 5 | FINGOLIMOD HYDROCHLORIDE | 1 | 0.0002 |
| 6 | MYCOPHENOLIC ACID | 5 | 0.0002 |
| 7 | TACROLIMUS OINTMENT 0.1% | 17 | 0.0001 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 | 0.0001 |
| 9 | TACROLIMUS | 17 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0014 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 5 | 0.0002 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 4 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 5 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 6 | Corticosteroid [EPC] | 25 | 0.0000 |
| 7 | Azole Antifungal [EPC] | 3 | 0.0000 |
| 8 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 9 | Purine Antimetabolite [EPC] | 1 | 0.0000 |